-
About 5% of Meitra’s revenue comes from overseas patients, largely from Oman. The share is expected to triple once additional capacity comes onstream, Faizal Kottikollon tells Moneycontrol
-
Instead of curbing doorstep delivery, India should use regulation to strengthen compliance, empower local chemists, and expand healthcare access
-
Star Health alone logged 13,300 complaints in FY24, over 10,000 of which were claim-related
-
Mutual funds raised allocations to autos for the second straight month in August, lifting sector weight to a 10-month high, aided by GST cuts and improving demand outlook. While tech made a modest comeback, private banks and healthcare saw allocations trimmed
-
The company has delivered a close to 4x return to investors since being recommended in MC Pro’s Discovery series
-
Optimistic guidance for FY26; the B2C segment should act as a key growth lever
-
The Indian healthcare market is experiencing robust growth and the hospital chain is uniquely placed in the paediatric segment
-
If the GST Council opts to exempt individual life and health policies from tax, insurers are likely to lose the benefit of input tax credit. Without ITC, potential benefits of a GST exemption are likely to capped while complicating operational matters for companies
-
This marks FLF III’s second investment, the first being its investment in La Renon Healthcare earlier this year.
-
Minister of State for Chemicals and Fertilisers Anupriya Patel said 16,912 Jan Aushadhi Kendras (JAKs) have been opened across the country till June 30, 2025.
-
Adverse drug reactions cause millions of hospitalisations annually, yet remain underreported in India. When it comes to the side-effects of drugs, self-help may become necessary. Greater awareness, education, and transparent communication are vital for ensuring truly patient-centric healthcare
-
According to the CMD of GIC Re, two major issues have prompted this move: fraudulent practices and discriminatory pricing by hospitals based on a patient’s insurance status
-
India’s hospital sector is entering a phase of professionalisation, consolidation, and capital-led transformation. PE funds, with their operational acumen and financial muscle, are emerging as catalysts for change—bridging gaps in healthcare infrastructure while enabling scale and sustainability
-
To see how far medical AI has come, Microsoft tested MAI-DxO on 304 real-world cases published in the New England Journal of Medicine, one of the world’s leading medical journals, and came out with flying colours
-
AI in radiology is no longer just a screening tool. It now collaborates in diagnosis, reduces errors, speeds up workflows, and supports clinical judgement - redefining its role from passive observer to active partner
-
The move marks a return to full-time startup operations for Rai, who left Oura in 2021. Rai will oversee product, telehealth, diagnostics, and clinical services as Loop deepens its healthcare focus
-
From Botox to hair transplant, fintechs like Fibe, SaveIN, QubeHealth, and Arogya Finance are turning India’s cosmetic care market into a click-and-credit playground with easy EMIs, checkout financing, partner clinics, and corporate tie-ups to drive the makeover.
-
Hyderabad-based Mapmygenome’s acquisition of Canada’s Microbiome Insights marks a critical moment in healthcare. It provides a platform to marry modern science with the wisdom and insight of Ayurveda. That, in turn, will allow India to lead a transformation in global healthcare
-
Large hospital companies have laid out plans to significantly expand their bed capacity over the next 3-4 years
-
Metro's IPO plans come at a time when the Indian healthcare sector is seeing a surge in public offers, reflecting investor confidence in the industry's growth prospects.
-
The investment, a mix of primary and secondary infusion, will fuel Nobel Hygiene's growth and market expansion as the adult diaper maker eyes an initial public offering
-
The Committee has suggested that the Ministry of Health work in tandem with all stakeholders to develop pharmacopeial standards
-
India's healthcare system faces a significant challenge: bridging the gap between world-class care and access for its growing middle class. To solve this, a unified, cashless, outcome-driven model with aligned stakeholders is essential for the future
-
India has three critical advantages, unmatched patient data, an expanding base of deep tech enterprise and a pool of entrepreneurs to deliver cutting edge healthcare solutions at a fraction of the cost incurred in the West. More importantly, these advances are not limited to a small pool of patients. They are affordable even in some of the poorest countries
-
The acquisition, third in the last three months, marks Perfios' entry into healthcare claims management as it continues to expand its BFSI platform through inorganic growth. Including IHX, Perfios has made five strategic acquisitions and one acqui-hire since 2022 to strengthen its position across the BFSI and fintech value chain.
